Doctor Murat Balaban appointed to consult for DBG Bio Energy B. V.

05 August, 2021: Doctor Murat Balaban, Co-founder and Executive Chairman of Episome Biotechnologies, has agreed to consult for DBG Bio Energy B.V.  In his consultation role, he will provide counsel, advice and expert knowledge with a specific focus on the patented enzymatic process, which prepares the industrial waste stream feedstock for the Anaerobic Digestion process, and its subsequent processing into BioLNG, CO2 and green fertiliser products.

Doctor Balaban has an extensive background in research, bioscience and medicine.  He has completed doctoral and post-doctoral research in a number of areas, such as Recombinant Bacterial Cellulase Production for Biofuel production and the characterization of transformation pseudopilus of Streptococcus pneumoniae . He holds a number of related patents and has published a number of publications, such as the “use of a cellulose hydrolysate for biogas production”. 

Dr. Murat Balaban, Co-Founder and Executive Chairman of Episome Technologies, in response, said: “This is a wonderful opportunity to apply my research learnings and patents into a full industrial production process, where we can upcycle environmentally damaging waste streams into BioLNG, green fertilizer and liquid CO2”.   

About DBG Bio Energy B.V.

DBG Bio Energy B.V., founded in the Netherlands, is committed to being an innovative and carbon-negative business, in support of society’s ambitious moves to a Carbon Net Zero, more environmentally-protected world.

DBG Bio Energy B.V., using a patented enzyme technology, will process high volumes of industrial biomass waste in a more environmentally sustainable, carbon-negative method than today.  With no emissions or harmful effluents, it will produce Bio-LNG for the energy and heavy transport sectors as well as green fertilizer and liquid CO2.